Carrie Lachance

Carrie Lachance (chief executive) discloses dealings in InfuSystem Holdings, Inc to SEC (Form 4). We count 32 filings; the first trade dates from 6 February 2020 and the latest from 23 September 2025.

Purchases make up the whole of the open-market record (5 purchases, €59k). The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 19 share grants and 8 option exercises. So far in 2025, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €15k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 25 September 2025 came the latest disclosure, a share grant for €170k in InfuSystem Holdings, Inc. The last purchase on record was published on 19 May 2025, which is 523 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.